plasminogen 中文意思是什麼

plasminogen 解釋
（血）纖（蛋白）溶酶原
  1. Effects of urokinase - type plasminogen activator receptor on sperm chemotactic response induced by urokinase - type plasminogen activator in mice

    尿激酶受體在尿激酶誘導小鼠精子趨化運動中的作用
  2. Prolactin inhibition of fsh - induced tissue type plasminogen activator expression in cultured rat granulosa cells liu yixun ; liu haizhen ; chen yijun ; ny t

    劉以訓;柳海珍;陳毅軍; ny t
  3. All the currently used thrombolytic agents are plasminogen activators, which are very efficient in restoring the blood flow. they can convert plasminogen into plasmin and thus degrade fibrin. despite the widespread use of established thrombolytic agents such as streptokinase, t - pa and u - pa, all these agents suffer from a number of inadequacies including resistance to reperfusion, occurrence of coronary reocclusion and bleeding complications

    介紹了國內外溶栓劑蛋白質工程方面的新進展，主要涉及了組織型纖溶酶原激活劑t - pa尿激酶型纖溶酶原激活劑u - pa鏈激酶sk葡萄球菌激酶sak dspa及tsv - pa的研究進展。
  4. They can convert plasminogen into plasmin and thus degrade fibrin. despite the widespread use of established thrombolytic agents such as streptokinase, t - pa and u - pa, all these agents suffer from a number of inadequacies including resistance to reperfusion, occurrence of coronary reocclusion and bleeding complications

    一些pa突變體及新型溶栓劑，如k2p tnk - pa和star等的臨床實驗結果表明它們在延長體內半壽期增強對血纖維蛋白選擇性和溶栓效率等方面有較大的改進。
  5. The quest continues for plasminogen activators with higher potency, specific thrombolytic activity, fibrin selectivity and longer half - life time. the recent progress in the protein engineering of plasminogen activators, including t - pa, u - pa, streptokinase, staphylokinase and other novel plasminogen activators, was presented in this article

    一些pa突變體及新型溶栓劑，如k2p tnk - pa和star等的臨床實驗結果表明它們在延長體內半壽期增強對血纖維蛋白選擇性和溶栓效率等方面有較大的改進。
  6. The gusto angiographic investigators : the comparative effects of tissue plasminogen activator, strptokinase, or both on coronary artery patercy, ventricular function and survival after acute myocardial infarction. n engl j med, 329 : 1615, 1993

    江隆福，游衛華，梁巖，等.直接經皮冠狀動脈腔內成形術與冠狀動脈內溶栓治療急性心肌梗塞的近期療效比較.中國危重病急救醫學雜志， 1998 ， 10 （ 1 ） : 35 - 38
  7. Tissue - type plasminogen activator t - pa

    組織型纖溶酵素原激活劑
  8. Tissue type plasminogen activator

    組織型纖溶酶原激活因子
  9. Construction of plasminogen activator and its expressive activity in human umbilical vein endothelial cell

    組織型纖溶酶原激活因子構建及其在人臍靜脈內皮細胞的表達活性
  10. The plasminogen ability in women with polycystic ovary syndrome

    多囊卵巢綜合征患者血纖溶能力的研究
  11. The relationship between behavior types and plasminogen activation system in patients with coronary heart disease

    冠心病患者行為類型與纖溶激活系統的關系
  12. Angiostatin, a multiple kringle ( 1 - 4 ) - containing fragment of plasminogen, is an effective natural inhibitor of tumor angiogenesis, which is a potent inhibitor of angiogenesis in vivo, and selectively inhibits endothelial cell proliferation and migration in vitro

    血管抑素angiostatin是纖溶酶原的內源片段，包括四個kringle結構，是一種重要的內源性新生血管生成抑制劑。
  13. Objective, clone tissue - type plasminogen activator ( t - pa ) gene and construct a new kind of recombinant vector containing human tissue - type plasminogon activator ( t - pa ) cnda neither cytotoxiaty nor actovating prot - oncogenes

    目的：克隆組織纖溶酶原激活物（ t - pa ）基因並構建一種無細胞毒性、不激活原癌基因的真核表達的pcdna3 . 1 （ + ） / t - pa質粒載體。
  14. Relationship between serum angiotension - converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with myocardial infarction

    心肌梗死患者血清血管緊張素轉換酶與血漿纖溶酶原激活劑抑制物1的活性及其相關性
  15. The relativity of the activity change of tissue - type plasminogen activator and type 1 plasminogen activator inhibitor in patients with cerebral infarction and defect of nerve function

    腦梗死患者血漿組織型纖溶酶原激活物和纖溶酶原激活物抑制物活性的變化與神經功能缺損的相關性
  16. Plasminogen secreted by the eosinophils inhibits the formation of platelet thrombus within the lumen and also dissolves fibrinoid substance, which reinforces fragile endothelilal walls or edematous interstitlum

    胞漿素原亦會溶解纖維組織，這現象更加強內皮細胞壁的脆弱性且使組成間質的水腫更為嚴重。
  17. Angiostatin ( as ) is a kind of polypeptide identified as a product of plasminogen cleavaged by protease. it blocks neovascularization by directly inhibiting endothelial cell proliferation and migration

    血管抑素（ angiostatin ， as ）是血漿纖溶酶原（ plasminogen ， plg ）經蛋白水解酶降解生成的多肽片段，是直接作用於血管內皮細胞的血管生成抑制劑。
  18. Western blot analysis showed that rhpk - 5 ( recombinant human plasminogen kringle 5, rhpk - 5 ) protein was recognized by mab same as native hpk - 5. the result suggested that we obtained correct gene sequence of hpk - 5 and got the purified rhpk - 5. section ii : construction of pbv220 / hpk - 5 vector for obtaining high - level hpk - 5 expression system, the hpk - 5 gene was recombined with plasmid pbv220 to construct the vector of pbv / hpk - 5

    Coli ）作為宿主，經sds - page分析，篩選表達量最高的菌株作為發酵用工程菌株；用western - blot方法鑒定hpk - 5因子的免疫學活性；用搖瓶發酵的方法，研究發酵培養基的體積（溶解氧） 、組成成份及誘導起始時間和誘導持續時間對目的蛋白表達量的影響，優化hpk - 5基因工程菌的表達條件。
  19. The mechanism of the regulation of calcium to the expression of tissue plasminogen activator in epidermis

    磷酸三鈣復合材料成骨細胞載體的體外實驗
分享友人
分享到 Line

分享到臉書